BR0213988A - Moduladores de poliamida de transcrição de cox2 - Google Patents

Moduladores de poliamida de transcrição de cox2

Info

Publication number
BR0213988A
BR0213988A BR0213988-0A BR0213988A BR0213988A BR 0213988 A BR0213988 A BR 0213988A BR 0213988 A BR0213988 A BR 0213988A BR 0213988 A BR0213988 A BR 0213988A
Authority
BR
Brazil
Prior art keywords
polyamide
cox2 gene
cox2
modulators
cell
Prior art date
Application number
BR0213988-0A
Other languages
English (en)
Inventor
Dennis P Phillion
Kathleen S Crowley
James K Bashkin
Barbara A Schweitzer
Barry L Burnette
Scott S Woodard
Original Assignee
Pharmacia Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Corp filed Critical Pharmacia Corp
Publication of BR0213988A publication Critical patent/BR0213988A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/635Externally inducible repressor mediated regulation of gene expression, e.g. tetR inducible by tetracyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"COMPOSTO DE POLIAMIDA E PROCESSO PARA REGULAR A EXPRESSãO DE GENE COX2". A invenção refere-se a processos e composições, que são fornecidos para a regulagem da expressão do gene COX2 em uma célula. O processo inclui selecionar uma composição de poliamida compreendendo N-metil pirrol (Py) e N-metil imidazol (lm) para fornecer uma ligação específica ao DNA em um alvo de gene COX2 em uma célula. A poliamida é então combinada com a célula contendo o gene COX2, em que a poliamida liga-se ao sítio alvo promotor de gene COX2 e regula a transcrição do gene COX2.
BR0213988-0A 2001-11-07 2002-11-07 Moduladores de poliamida de transcrição de cox2 BR0213988A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34485901P 2001-11-07 2001-11-07
US41940502P 2002-10-18 2002-10-18
PCT/US2002/035718 WO2003040337A2 (en) 2001-11-07 2002-11-07 Polyamide modulators of cox2 transcription

Publications (1)

Publication Number Publication Date
BR0213988A true BR0213988A (pt) 2004-08-31

Family

ID=26994132

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0213988-0A BR0213988A (pt) 2001-11-07 2002-11-07 Moduladores de poliamida de transcrição de cox2

Country Status (8)

Country Link
US (1) US20030119891A1 (pt)
EP (1) EP1442022A4 (pt)
JP (1) JP2005508181A (pt)
AU (1) AU2002356916A1 (pt)
BR (1) BR0213988A (pt)
CA (1) CA2466391A1 (pt)
MX (1) MXPA04004366A (pt)
WO (1) WO2003040337A2 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8993609B2 (en) 2006-05-04 2015-03-31 Nanovir, Llc Compounds for treating papilloma virus infection
ATE555108T1 (de) * 2006-05-04 2012-05-15 Nanovir Llc Polyamide zur behandlung des menschlichen papilloma-virus
BR112014008464A2 (pt) 2011-10-10 2017-04-11 Nanovir Llc composto; composição farmacêutica; método para ligar dna de fita dupla com especificidade para sequência; método para reduzir ou inibir a proliferação de células de papiloma ou neoplásticas; método para tratar células infectadas por vírus; e método para tratar hpv em um indivíduo
US9982020B2 (en) 2011-10-10 2018-05-29 Nanovir Llc Antiviral compounds and methods for treating infections caused by double-stranded DNA viruses

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6403302B1 (en) * 1992-09-17 2002-06-11 California Institute Of Technology Methods and compositions for triple helix formation
US6143901A (en) * 1996-07-31 2000-11-07 Genesoft, Inc. Complex formation between dsDNA and pyrrole imidazole polyamides
US6090947A (en) * 1996-02-26 2000-07-18 California Institute Of Technology Method for the synthesis of pyrrole and imidazole carboxamides on a solid support
EP0968186A1 (en) * 1996-02-26 2000-01-05 California Institute Of Technology Improved polyamides for binding in the minor groove of double stranded dna
US5998140A (en) * 1996-07-31 1999-12-07 The Scripps Research Institute Complex formation between dsDNA and oligomer of cyclic heterocycles
DE19707205A1 (de) * 1997-02-24 1998-09-03 Piller Gmbh Aufwickeleinrichtung
CA2286232A1 (en) * 1997-04-06 1998-11-05 California Institute Of Technology Dna-binding pyrrole and imidazole polyamide derivatives
WO2000029022A1 (en) * 1998-11-12 2000-05-25 Algos Pharmaceutical Corporation Cox-2 inhibitors in combination with centrally acting analgesics
ES2160062B1 (es) * 1999-07-12 2002-05-16 Esteve Labor Dr Linea celular que comprende el promotor de la ciclooxigenasa-2 (cox-2) y un gen testigo y su empleo en la busqueda de inhibidores selectivos de la induccion transcripcional de cox-2.
CA2422520A1 (en) * 2000-07-11 2002-01-17 Universite De Geneve Linked, sequence-specific dna-binding molecules

Also Published As

Publication number Publication date
CA2466391A1 (en) 2003-05-15
AU2002356916A1 (en) 2003-05-19
US20030119891A1 (en) 2003-06-26
WO2003040337A2 (en) 2003-05-15
WO2003040337A3 (en) 2004-03-11
MXPA04004366A (es) 2004-09-10
EP1442022A4 (en) 2005-05-04
EP1442022A2 (en) 2004-08-04
JP2005508181A (ja) 2005-03-31

Similar Documents

Publication Publication Date Title
Luebke et al. The CsoR‐like sulfurtransferase repressor (CstR) is a persulfide sensor in S taphylococcus aureus
DE69534472D1 (de) Transkriptionsmodulatoren tetracyklin-regulierte
BR0012984A (pt) Método para tratar um estado associado com o mc4-r em um mamìfero, composto de ligação ao mc4-r, e, composição farmacêutica
ATE477277T1 (de) Weniger immunogene bindungsmoleküle
CY1111278T1 (el) Συστημα ασφαλειας
CA2278151A1 (en) Heregulin variants
BR9808960A (pt) Composição de resina lìquida curável
BR0111020A (pt) Composição de revestimento fotoativável
BRPI0519344A2 (pt) promotor induzÍvel por l-lisina
NO20052543D0 (no) 3-aminopyrrolidinderivater som modulatorer av kjemokinreseptorer.
BRPI0906104B8 (pt) derivado de ácido peptonucleico, composição farmacêutica contendo uma quantidade terapeuticamente eficaz do derivado de ácido peptonucleico, método de utilização do derivado de ácido peptonucleico e composto
BR0316455A (pt) Molécula nucleica e polinucleotìdeo isolados, célula de planta, planta e planta transgênica e métodos de regulação do teor de lignina de uma planta e de obtenção de madeira
BR0317650A (pt) Planta transformada, sequência de nucleotìdeo, estrutura de gene, vetor, processo para modificar o teor de reserva de armazenagem em plantas, e, uso de uma planta
BR0008018B1 (pt) processo e aparelho para o controle de mistura em um combinador farmacêutico.
DE602005011974D1 (de) Strahlungshärtbare glanzarme pulverlacke
WO2002068680A3 (en) Compositions and methods for regulating endogenous inhibitor of atp synthase, including treatment for diabetes
BR9908730A (pt) Processos para o isolamento retificativo e para a preparação de ácido (met) acrìlico
BR0213988A (pt) Moduladores de poliamida de transcrição de cox2
BR9800641A (pt) Construção de ácido nucléico para a expressão regulada pelo ciclo celular de genes estruturais.
DK0724637T3 (da) Kortikotropinfrigørende faktor2-receptorer
BR9808854A (pt) Processo para preparação de um composto, e, composto
BR0309783A (pt) Inibidores de quinases de pontos de controlo (wee1 e chk1)
ATE459672T1 (de) Härter
DE50110667D1 (de) Verfahren zur Herstellung von Organosilylalkylpolysulfanen
ATE371732T1 (de) Verfahren zur genexpression

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 4A, 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2034 DE 29/12/2009.